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HIV-1 Nef is clearly essential for efficient viral replication
in vivo, but it has been difficult to determine why. Recent
evidence that Nef specifically activates a PAK-dependent
signaling cascade may be the first step in defining the
mechanism of action of this enigmatic viral protein.
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Human immunodeficiency virus-1 (HIV-1) and the related
simian immunodeficiency viruses (SIVs) encode only nine
gene products, so it is perhaps surprising that four of these
are largely dispensable for viral replication in culture. This
presumably reflects the very different environment these
viruses encounter in infected patients or primates com-
pared to tissue culture flasks. Studies of the HIV-1 Nef
protein have made this point particularly clearly: Nef is
essential for efficient viral replication and pathogenesis in
vivo, yet exerts only a minimal effect on viral replication in
many tissue-culture settings [1]. This modest phenotype
has complicated investigation into the role and mechanism
of action of Nef, a problem made even more difficult by
the sometimes marked variation observed when different
T-cell lines or Nef isolates are used. Nevertheless, signifi-
cant progress has now been made towards defining the
role of Nef in the infected cell and identifying potential
mechanisms of action (Fig. 1).
Nef is a myristoylated, membrane-associated, cytoplasmic
protein that is expressed early in the HIV-1 life cycle
(reviewed in [2]). The first, and still most consistent,
activity reported for Nef is the internalization and degra-
dation of the cell-surface CD4 receptor for HIV-1. This
effect requires a target sequence located in the cytoplas-
mic domain of the CD4 receptor and is highly specific [3].
However, the mechanism by which Nef mediates this
effect is not known, and there is little evidence for a direct
interaction between Nef and CD4. Downregulation of
CD4 can clearly block viral superinfection and may facili-
tate the release of progeny HIV-1 virions by infected cells
[2]. It remains unclear, however, to what degree CD4
downregulation can explain the need for Nef in vivo, espe-
cially given that the viral Vpu and Envelope proteins are
also known to inhibit cell-surface expression of CD4 [2].
Although the effect of Nef on viral replication in culture
has in the past been controversial, several recent studies
have now clearly demonstrated that Nef can enhance both
the infectivity of progeny virions and the rate of viral spread
in culture. While the precise step in the viral replication
cycle affected by loss of Nef function remains uncertain,
evidence has been presented indicating that it occurs early
after infection, before completion of the reverse transcrip-
tion process [4,5]. This as yet ill-defined defect can be
rescued by expression of Nef in trans in producer cells, but
not by expression in target cells. Overall, these data
strongly suggest that Nef expression in infected cells leads
to a modification of progeny virions to a more infectious
form. It is therefore of interest to note that low levels of Nef
have been found to be packaged into HIV-1 virions [6].
The third, and currently most controversial, property of
Nef in culture relates to its effect on the activation state of
cells. While several reports have suggested that Nef can
affect signal transduction in T cells, there remains consid-
erable disagreement as to whether this results in an
enhancement or an inhibition in the level of activation of
these cells [2]. In principle, one would predict that meta-
bolic activation of T cells by Nef would be more likely to
enhance virus replication, particularly in contexts, such as
in vivo, where most cells are nondividing. In fact, the
unusual Nef allele found in the SIV isolate pbj14, which
has been convincingly shown to enhance cellular activa-
tion, has also been clearly shown to promote viral replica-
tion on resting T cells in culture [7].
As Nef appears to exert multiple, apparently disparate
effects in cultured cells (Fig. 1), the question arises
whether these activities are indeed distinct or whether
they are simply different manifestations of a single Nef
activity. Strong support for the former hypothesis has
come from the finding that disruption of a conserved
proline-rich motif in Nef blocks its ability to enhance
virion infectivity without affecting CD4 downregulation
[8]. There is thus an evolving consensus that Nef affects
viral replication in two, or possibly more, different ways,
but until recently little progress has been made in defining
the molecular basis for these effects. 
This position is now quickly changing, however. Two
years ago, Sawai et al. [9] reported that immunoprecipita-
tion of both HIV-1 and SIV Nef also resulted in the spe-
cific coprecipitation of two serine/threonine kinases, p62
and p72, a finding of obvious relevance to the search for
intracellular targets for Nef function. Three recent papers,
one of which is published in this issue of Current Biology,
have now presented evidence that these kinases are
related to the p21-activated kinase (PAK) family of signal
transduction molecules [10–12].
PAKs are normally regulated by one of two small Ras-like
GTP-binding proteins, Rac1 and Cdc42, which in turn are
functionally linked to several cell-surface receptors. Acti-
vation of one or more of these receptors results in activa-
tion of Rac1 and Cdc42, which then bind to and activate
target PAKs by inducing their autophosphorylation. The
PAKs are then believed to activate a protein kinase
cascade, involving members of the mitogen activated
protein kinase (MAPK) family, leading eventually to the
phosphorylation and activation of target transcription
factors, such as Jun and serum response factor (SRF) [13].
It is important to note that activation of Rac1 and Cdc42
can exert profound effects on the actin cytoskeleton and
thus has the potential to affect such processes as cell
mobility, endocytosis and cytokinesis [14].
The evidence that Nef specifically associates with, and acti-
vates, two novel PAK isoforms in expressing cells is com-
pelling, although the precise identification of the relevant
PAKs, and the reconstitution of the binding and activation
reaction in vitro, has not been reported. Thus, immunopre-
cipitation of PAKs from Nef-expressing cells resulted in the
coprecipitation of Nef [11]. Similarly, the autophosphory-
lated kinases that are coprecipitated with Nef were also
specifically recognized by anti-PAK antisera [10,11]. Fur-
thermore, phosphopeptide maps of p62 and p72 kinases iso-
lated from Nef-expressing T-cells by immunoprecipitation
with anti-PAK antisera were indistinguishable from the
maps of p62 and p72 kinases that were coprecipitated by
anti-Nef antisera [11]. Finally, Lu et al. [12] provided
evidence that the transcriptional activity of SRF, an estab-
lished downstream effector of the PAK signaling cascade
[13], is significantly enhanced in Nef-expressing cells.
The interaction of Nef with the p62 and p72 PAK-like
kinases appears to result in, or reflect, their activation in
Nef-expressing cells [11,12]. An important question is
therefore whether the Rac1 and Cdc42 GTP-binding pro-
teins that normally regulate PAKs play a role in this
process. One line of evidence in support of this hypothesis
is the finding of Lu et al. [12] that a dominant-negative
form of a known isoform of PAK, which retains an intact
GTPase-binding domain but lacks the kinase domain, can
block the binding and/or activation of the endogenous p62
PAK isoform by Nef. This implies that Rac1 and/or Cdc42
do play a direct role in the Nef-induced activation process.
In further support of this inference, activation and/or
binding of p62 PAK by Nef was not only blocked by dom-
inant-negative forms of Rac1 and Cdc42, but was also sig-
nificantly potentiated by constitutively active forms of the
two GTP-binding proteins [10,12].
Given that Nef binds to, and activates, two novel PAK
isoforms in infected cells, how does this explain the
known effects of Nef on the HIV-1 replication cycle? At
present, the answer to this question remains unclear. If
Nef specifically targets PAKs and hence, presumably, the
downstream kinase cascade, this would be expected to
result in the activation of specific transcription factors
[13]. One of the known targets of this signal transduction
pathway is Jun, a component of the transcription factor
AP-1. AP-1 is known to play a direct role in the activation
of T-cell specific genes, and also participates in the forma-
tion of other transcription factors, such as NF-AT and
NF-IL-2, that are important in activated T cells. Clearly,
therefore, PAK activation could have a significant effect
on T-cell activation (Fig. 1). 
Phosphorylation of components of the HIV-1 virion, and
particularly of the matrix protein, has been proposed to
facilitate early events in the viral replication cycle [15]. It
is therefore possible that Nef might promote the appro-
priate phosphorylation of specific virion components by
recruiting PAKs to the virion during morphogenesis at the
cell membrane. Finally, an important question is whether
the Nef–PAK interaction only affects steps downstream
of PAK, or whether Nef might also activate Rac1/Cdc42.
If the latter is the case, one would predict that Nef
expression would significantly perturb the normal regula-
tion of actin polymerization in the cell [14], resulting in
potential effects on processes, such as endocytosis, that
are obviously relevant to the issue of virion release and
receptor internalization.
Although it remains uncertain how the interaction of Nef
with PAK affects Nef function, this interaction does
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Figure 1
The PAK–Nef connection. Expression of Nef in HIV-1 infected cells
results in at least three phenotypic effects, as described in the text and
here indicated by yellow boxes. Activation of PAK by Nef would result in
activation of several cellular transcription factors and thus could explain
effects of Nef on T-cell activation (1). Recruitment of PAK to virions by
Nef could enhance virion infectivity by modifying the phosphorylation
pattern of virion structural proteins (2). The potential relevance of PAK
activation to CD4 downregulation by Nef is more difficult to discern;
however, the hypothetical activation of the Rac1/CDC42 GTP-binding
proteins involved in PAK signaling [12] could affect actin polymerization
and, hence, membrane receptor internalization (3).
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appear to be important. A missense mutation of SIV Nef
that blocks PAK binding was found to inhibit SIV replica-
tion and pathogenesis [11]. Although this mutation could,
of course, be more pleiotropic than expected, these obser-
vations are nevertheless consistent with the notion than
PAK is an essential target for Nef function. It will certainly
be of great interest to find out why.
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